£107.98

Springer - New Agents for the Treatment of Acute Lymphoblastic Leukemia

Price data last checked 60 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 31 days • 31 data points (No recent data available)

Historical
Generating forecast...
£107.98 £107.38 £107.51 £107.64 £107.77 £107.90 £108.04 09 April 2026 16 April 2026 24 April 2026 01 May 2026 09 May 2026

Price Distribution

Price distribution over 31 days • 2 price levels

Days at Price
Current Price
19 days 12 days · current 0 5 10 14 19 £107 £108 Days at Price

Price Analysis

Most common price: £107 (19 days, 61.3%)

Price range: £107 - £108

Price levels: 2 different prices over 31 days

Description

New Agents for the Treatment of Acute Lymphoblastic Leukemia provides a deep look into the evolving landscape of cancer research and therapy. While cancer formation follows a complex path that often takes years to reach a clinically apparent stage, this book addresses the many questions arising from modern medical advancements. This text examines specific strategies for using new agents and identifies potential targets of therapy for Acute Lymphoblastic Leukaemia (ALL). Although current treatments are associated with high cure rates, the book addresses the serious challenges of relapsed disease, which often results in poor outcomes. Furthermore, it explores the issues of therapy that is unduly prolonged and toxic. Designed for medical professionals and researchers, this Springer publication offers a focused examination of how new therapeutic agents can change the approach to treating ALL. It serves as a necessary resource for understanding the current state of oncology and the ongoing efforts to improve patient outcomes in the face of relapse and treatment toxicity.

Key Features

Examines strategic uses for new agents in the treatment of Acute Lymphoblastic Leukaemia (ALL).

Identifies possible targets of therapy to help address the complexities of this disease.

Provides insight into the challenges of relapsed disease and its poor clinical outcomes.

Addresses the issues surrounding prolonged and toxic therapy in current medical practices.

Explores the complex natural history of cancer formation and its clinical development.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
01 October 2014
Listed Since
01 October 2014

Barcode

No barcode data available

Similar Products You Might Like

Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside
98% match

Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside

Springer

£111.93 17 Jun 2026
Acute Leukemias (Hematologic Malignancies)
98% match

Acute Leukemias (Hematologic Malignancies)

Springer

£103.69 16 Jun 2026
Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)
98% match

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Springer

£108.92 10 Jun 2026
Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)
98% match

Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)

Humana

£163.59 29 Jun 2026
Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)
98% match

Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)

Humana

£141.73 17 Jun 2026
Chemotherapy for Leukemia: Novel Drugs and Treatment
98% match

Chemotherapy for Leukemia: Novel Drugs and Treatment

Springer

£105.45 09 Mar 2026
Acute Lymphoblastic Leukemia: A Clinical Study
98% match

Acute Lymphoblastic Leukemia: A Clinical Study

Foster Academics

£59.99 13 Jun 2026
Acute Lymphoblastic Leukemia: Etiology, Pathogenesis, and Treatments (Cancer Etiology, Diagnosis and Treatments)
98% match

Acute Lymphoblastic Leukemia: Etiology, Pathogenesis, and Treatments (Cancer Etiology, Diagnosis and Treatments)

£140.11 13 Jun 2026
Childhood Acute Lymphoblastic Leukemia
98% match

Childhood Acute Lymphoblastic Leukemia

Springer

£66.74 24 Jun 2026
Acute Myelogenous Leukemia (Contemporary Hematology)
97% match

Acute Myelogenous Leukemia (Contemporary Hematology)

Humana

£164.16 12 Jun 2026
Pediatric Acute Lymphoblastic Leukemia
97% match

Pediatric Acute Lymphoblastic Leukemia

Springer

£95.70 10 Jun 2026
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
97% match

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

CRC Press

£147.25 13 Apr 2026
Leukemias
97% match

Leukemias

Springer

£76.02 18 Apr 2026
Molecular Genetics and Therapy of Leukemia: 84 (Cancer Treatment and Research, 84)
97% match

Molecular Genetics and Therapy of Leukemia: 84 (Cancer Treatment and Research, 84)

Springer

£212.33 11 Jun 2026
Hematologic Malignancies: Acute Leukemias
97% match

Hematologic Malignancies: Acute Leukemias

Springer

£155.47 13 May 2026
Humana Leukemia: Methods and Protocols: 538 (Molecular Biology)
97% match

Humana Leukemia: Methods and Protocols: 538 (Molecular Biology)

Humana

£102.16 19 Apr 2026
Pathogenesis and Treatment of Leukemia
97% match

Pathogenesis and Treatment of Leukemia

Springer

£127.00 13 Jun 2026
Contemporary Management of Acute Lymphoblastic Leukemia
97% match

Contemporary Management of Acute Lymphoblastic Leukemia

Jaypee Brothers Medical Publishers

£88.86 12 Jun 2026
Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)
97% match

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Springer

£149.65 14 Apr 2026
Humana Acute Myelogenous Leukemia - Contemporary Hematology
97% match

Humana Acute Myelogenous Leukemia - Contemporary Hematology

Humana

£49.00 25 Apr 2026
Acute Myeloid Leukemia (Hematologic Malignancies)
97% match

Acute Myeloid Leukemia (Hematologic Malignancies)

Springer

£88.17 12 Jun 2026
Springer Childhood Leukemia: A Practical Handbook - Oncology
97% match

Springer Childhood Leukemia: A Practical Handbook - Oncology

Springer

£110.18 28 Apr 2026
CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)
97% match

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

£159.57 12 Jun 2026
Academic Press - Treatment of Leukemia and Lymphoma Vol 51
97% match

Academic Press - Treatment of Leukemia and Lymphoma Vol 51

Academic Press

£175.00 02 May 2026